Corcept Therapeutics Incorporated shares owned by Evanson Asset Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Evanson Asset Management
from 13F filings
Historical chart of Evanson Asset Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Evanson Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Corcept Therapeutics Incorporated by Evanson Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 14k | 83.11 |
| 2025-06-30 | $1.2M | 16k | 73.40 |
| 2025-03-31 | $2.4M | 21k | 114.22 |
| 2024-12-31 | $1.1M | 21k | 50.39 |
| 2024-09-30 | $1.1M | 23k | 46.28 |
| 2024-06-30 | $762k | 23k | 32.49 |
| 2024-03-31 | $591k | 23k | 25.19 |
| 2023-12-31 | $1.0M | 31k | 32.48 |
| 2023-09-30 | $946k | 35k | 27.25 |
| 2023-06-30 | $942k | 42k | 22.25 |
| 2023-03-31 | $862k | 40k | 21.66 |
| 2022-12-31 | $1.0M | 40k | 25.64 |
| 2022-09-30 | $1.0M | 40k | 25.63 |
| 2022-06-30 | $946k | 40k | 23.77 |
| 2022-03-31 | $896k | 40k | 22.51 |
| 2021-12-31 | $788k | 40k | 19.80 |
| 2021-09-30 | $885k | 40k | 22.24 |
| 2021-06-30 | $876k | 40k | 22.01 |
| 2021-03-31 | $947k | 40k | 23.79 |
| 2020-12-31 | $1.0M | 40k | 26.16 |
| 2020-09-30 | $693k | 40k | 17.41 |
| 2020-06-30 | $669k | 40k | 16.81 |
| 2020-03-31 | $473k | 40k | 11.88 |
| 2019-12-31 | $482k | 40k | 12.11 |
| 2019-09-30 | $563k | 40k | 14.15 |
| 2019-06-30 | $444k | 40k | 11.16 |
| 2019-03-31 | $467k | 40k | 11.73 |
| 2018-12-31 | $532k | 40k | 13.37 |
| 2018-09-30 | $558k | 40k | 14.02 |
| 2018-06-30 | $626k | 40k | 15.73 |
| 2018-03-31 | $655k | 40k | 16.46 |
| 2017-12-31 | $719k | 40k | 18.07 |
| 2017-09-30 | $768k | 40k | 19.30 |
| 2017-06-30 | $470k | 40k | 11.81 |
| 2017-03-31 | $436k | 40k | 10.95 |
| 2016-12-31 | $289k | 40k | 7.26 |
| 2016-09-30 | $148k | 23k | 6.49 |
| 2016-06-30 | $124k | 23k | 5.44 |
| 2016-03-31 | $107k | 23k | 4.69 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated